Helixmith Dividend yield




   KRW/share 
 Price  33,000.00
 Dividend  0.00
 Earnings  -3,113.21
 Cash-flow  -1,096.35
 Book value  5,689.66
 Equity  4,804.34

Helixmith is part of Pharmaceuticals and Biotechnology business, which is part of Health Care industry. Helixmith is a company from Korea, and his stocks are publicly traded.

Helixmith paid a total dividend of 0 million KRW last year, for a market value of 1,122,000 millions (Market Cap 960,934 millions). Dividend per share of Helixmith is 0.00 KRW, and his stock market price 33,000.00 KRW.

According to the chart below where dividend yield is displayed, Helixmith, has a dividend yield of 0%, amount in contrast with the positive dividend offered by both the market average and companies from Korea, Health Care industry, and Pharmaceuticals and Biotechnology sector. This lack of dividends of Helixmith might harm the evolution of share price if the company is not clearly expanding his business.

In addition, you should compare Helixmith dividend yield with other Pharmaceuticals and Biotechnology companies or firms from Korea.

Dividend yield of Helixmith

Helixmith Dividend Payout

About the ability of Helixmith to maintain his current dividend of KRW 0.00 per share, an amount that accounts for 0.00%, we should study its payout ratio both on earnings and on cash-flows (see chart below). Helixmith payout on ernings is currently 0.00%, which is lower than the market average and companies in his industry and sector.

The following figure shows payout ratios over earnings and cashflow of Helixmith, compared againt world market average, Korea companies, Health Care industry and Pharmaceuticals and Biotechnology sector companies.

Helixmith payout

Helixmith Dividend History

Year Yield  KRW  Paypout  Shares* 
Present0.00%0.000.00%34
20190.00%0.000.00%21

*In millions

Helixmith Stock performance

Finally, last moth Helixmith showed a return of 21.30% compared to a worldwide 3.99% average, and a 3.09% of Health Care firms. Over the last year, the company obtained a -52.60% versus a worldwide performance of a 6.65%. More detailed information can be seen in the following graph for Korea and Pharmaceuticals and Biotechnology firms.

Helixmith stock and market return